Pharmacy operator, employees charged in $200M health insurance fraud scheme

Four Mississippi residents have been indicted on charges of defrauding insurers of more than  $200 million after creating expensive and unnecessary medications, The New York Times reports.

Advertisement

Hope Thomley, Randy Thomley and Glenn Beach Jr. of Advantage Pharmacy are charged in a scheme to make compounded medications that insurers would pay upward of $10,000 for regardless of a  patient’s medical needs. Advantage pharmacist Jason May and marketer Jay Schaar already have pleaded guilty to their roles in the fraud. Marketers allegedly recruited providers to write false prescriptions for patients they never examined.

Gregory Parker is a nurse practitioner accused of prescribing the medications and lying to federal investigators. A 78-year-old physician already has been sentenced to more than three years in prison for his role in the scheme.

One of the compounded drugs was a dietary supplement composed of over-the-counter ingredients for which insurers paid thousands of dollars per bottle.

More articles on legal and regulatory issues:

Police officer admits assaulting patient at New Jersey hospital
Nurse gets jail time for $393K billing fraud scheme
Prime Healthcare can sue Humana over alleged Medicare Advantage underpayments

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.